VENCLYXTO (R) (Venetoclax): New in the Therapy of High-Risk Patients with chronic lymphatic Leukemia

Nienstedt, M

Nienstedt, M (reprint author), AbbVie Deutschland GmbH & Co KG, Ludwigshafen, Germany.

ONCOLOGY RESEARCH AND TREATMENT, 2017; 40 (3): 157

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索